Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for diabetes and weight loss, with many breast reconstruction candidates being prescribed these medications. However, perioperative risks remain unclear. This study evaluated the association between GLP-1RA use and postoperative complications in implant-based and autologous tissue breast reconstruction. Methods: A retrospective analysis of TriNetX identified patients undergoing implant-based or autologous tissue breast reconstruction. Preoperative GLP-1RA users were compared to matched controls. Patients were propensity score matched (1:1 and 1:3) for demographics and comorbidities including body-mass index and timing of reconstruction (delayed vs. immediate). Ninety-day outcomes were assessed using logistic regression. Results: Between 2014 and 2024, 57,987 patients were identified, of which 823 were GLP-1RA users. Of those users, 326 patients undergoing implant-based reconstruction and 51 patients undergoing autologous reconstruction were matched to controls. In implant-based cohorts, GLP-1RA use was associated with increased odds of implant failure (1:1 OR 1.70, 95% CI 1.18–2.45, p = 0.0046), wound healing complications (1:1 OR 1.90, p = 0.027), and higher readmission/ED utilization (1:1 OR 1.80, 95% CI 1.04–3.21, p = 0.040). No significant differences were observed for hematoma, seroma, or thromboembolism. In autologous reconstruction, GLP-1RA use was not associated with increased risks. Conclusions: GLP-1RA use is linked to higher rates of implant failure, wound healing complications, and readmission in implant-based breast reconstruction only. These findings highlight the need for risk stratification and counseling of GLP-1RA users undergoing implant-based procedures and for further research investigating the implications of perioperative use of these agents in plastic surgery.
OBJECTIVES: To compare stiffness, displacement, and load to failure (LTF) patterns of a novel anterior pelvic plating technique, W-plating, to superior parasymphyseal plating (SPSP) in anterior posterior compression type III (APC III) pelvic ring injuries in a biomechanical model. METHODS: Twelve fourth generation composite pelves with induced APC III injuries stabilized with posterior screw fixation and either W-plating or SPSP were stressed via the Instron machine under single leg stance (SLS) axial load and external rotation (ER) load. Motion was analyzed at the pubic symphysis (PS) and sacroiliac joints (SIJ). PS and SIJ displacement, rotation, and stiffness were compared between the W-plate and SPSP groups under simulated stressed conditions. T-test was used to compare means and significance was set at p<0.05. Unadjusted p-values were reported alongside effect sizes (Cohen’s d) and 95% confidence intervals (CI) to provide additional context regarding the magnitude and potential biomechanical relevance of the observed differences RESULTS: The W-plate demonstrated less inferior PS displacement than the SPSP under SLS with a large observed effect size (0.5 ± 0.4 mm vs 1.2 ± 0.5 mm, respectively, Cohen’s d = 1.47). Average PS displacement also demonstrated a large effect size favoring the W-plate construct (Cohen’s d = 1.07), though statistical significance was not reached (0.3 ± 0.3 mm vs 0.7 ± 0.3 mm respectively, p = 0.07). There were no significant differences in stiffness in the SLS for the W-plate versus SPSP (98.9 ± 11.2 vs 105 ± 6.6 N/mm, respectively, p = 0.6) or in ER (4.4 ± 2.2 v 3.1 ± 1.6, respectively, p = 0.3). When loaded to failure, the W-plate and the SPSP both failed at the posterior fixation with no significant difference between groups (1411± 221 v 1545 ± 225 N, respectively p = 0.4). CONCLUSIONS: In a biomechanical analysis of induced APC-III pelvic ring injury, W-plating performed similarly to SPSP in stiffness, displacement, and LTF. W-plating for anterior pelvic ring fixation was found to be biomechanically similar to SPSP with potentially increased resistance to anterior ring displacement. LEVEL OF EVIDENCE: V